Same Indication

Methotrexate vs Spironolactone

Methotrexate vs Spironolactone: Overview

This comparison examines the pharmacological differences between Methotrexate and Spironolactone.

Mechanism of Action

Methotrexate: Dihydrofolate reductase inhibitor.

Spironolactone: Mineralocorticoid receptor antagonist.

Pharmacokinetics

Half-life: Methotrexate — 3-10 hours; Spironolactone — 1.4 hours.

Chemical Properties

Molecular Formula: Methotrexate — C20H22N8O5; Spironolactone — C24H32O4S.

Molecular Weight: Methotrexate — 454.4400 g/mol; Spironolactone — 416.5740 g/mol.

Type: Methotrexate — Small molecule; Spironolactone — Small molecule.